Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
4
×
eli lilly
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
johnson & johnson
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
vaccines
wisconsin blog main
wisconsin top stories
abbvie
aduro biotech
agenus
alzheimer's disease
biogen
bristol-myers squibb
What
bio
4
×
companies
4
×
drug
roundup
latest
nash
new
news
pharmaceutical
price
alzheimer’s
approval
approved
bets
biogen’s
biopharmaceutical
cancer
comes
convo
cut
date
deal
different
digital
disease
earlier
effective
enticed
epidemic
evidence
fail
failures
fatty
fda
frenzied
gene
growing
hasn’t
increases
known
Language
Current search:
bio
×
companies
×
deals
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines